Figure 2 depicts the frequency of the most common genetic alterations identified in GC tumors from PRH, emphasizing their potential influence on the deregulation of key signaling pathways, including WNT/β‐catenin, MAPK, PI3K, TGF‐β, and p53 pathways. The gene discussed is TGFB1; the disease is gastric cancer.